Study of TEV-50717 in Relieving Tics Associated With Tourette Syndrome

- Tourette Syndrome
- Completed

Study Title: A Study to Test if TEV-50717 is Effective in Relieving Tics Associated With Tourette Syndrome (TS)

Teva Identifier: TV50717-CNS-30060 | 2017-002976-24

ClinicalTrials.gov Identifier: NCT03571256

Study Status: Completed

Trial Condition(s): Tourette Syndrome

Interventions: Drug: TEV-50717 | Drug: Placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

Participation criteria and map of study locations

Key Participation Requirements

Gender: Female, Male

Age group: Child

Age Range: 6 Years to 16 Years

Trial Duration: May 31, 2018 - December 9, 2019

Phase: Phase 3

Additional info

Plain Language Summary

Study Type

Interventional